Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Senomyx Granted Exclusive License to TRPM5 Patent Rights Covering Modulation of Sweet, Bitter, and Savory Tastes
April 11th, 2007
Senomyx, Inc. (NASDAQ:SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food and beverage industry, announced that it has entered into an exclusive, worldwide license agreement with The Queens Medical Center, Honolulu, Hawaii, covering patent rights relating to the use of the TRPM5 ion channel to modulate sweet, bitter, and savory tastes. The agreement covers intellectual property regarding methods of screening for TRPM5 taste modulators, and allows Senomyx to develop and commercialize flavor ingredients discovered using proprietary assay systems. "TRPM5 is an ion channel that mediates the signal...
Source: Medical Patent Law Weekly (2007-04-11)
|
